Sam Tomy K/ LinkedIn
Jun 5, 2026, 02:29
Sam Tomy K: Antinuclear Antibody Testing and Its Role in Autoimmune Disease Diagnosis
Sam Tomy K, Laboratory Technician at MVR Cancer Centre and Research Institute, shared a post on LinkedIn:
“Understanding the ANA Test — A Key Marker in Autoimmune Diagnostics
The Antinuclear Antibody (ANA) test plays a crucial role in detecting autoimmune disorders such as lupus, Sjögren syndrome, systemic sclerosis, and mixed connective tissue disease.
In the laboratory, ANA testing by indirect immunofluorescence on HEp-2 cells remains the gold standard for identifying autoantibodies and interpreting fluorescence patterns.
Key highlights:
- ANA patterns and their clinical significance
- HEp-2 cell indirect immunofluorescence
- Titer interpretation
- Common autoimmune associations
- Importance of quality control in ANA testing
As medical laboratory professionals, understanding the science behind ANA testing helps improve diagnostic accuracy and patient care.”
Stay updated with Hemostasis Today.
-
Jun 5, 2026, 01:54Abdul Mannan: What Is the Most Common “Freeloading” Medication Seen in Anticoagulated Patients?
-
Jun 4, 2026, 17:38Francesco Tannura: The Potential of the Khorana Risk Score for PE Stratification in Lung Cancer
-
Jun 4, 2026, 16:17Nada Fahd: Immune Thrombocytopenia (ITP) – Outpatient vs Inpatient Management
-
Jun 4, 2026, 16:16Saoud Hassan: Hemostasis and Blood Coagulation Pathway – Simplified
-
Jun 4, 2026, 16:15Farooq Khan: Vacuuming Blood Clots in Seconds
-
Jun 4, 2026, 16:14Kayla Garrett: Confirming Or Excluding APS Relies On Accurate Lupus Anticoagulant Testing
-
Jun 4, 2026, 16:14Scott Colton: Exploring the Key Differences Between Anticoagulant and Antiplatelet Medications
-
Jun 4, 2026, 16:13Wolfgang Miesbach: Is Bone Health a Silent Comorbidity In Haemophilia and VWD?
-
Jun 4, 2026, 15:35Carolina La Mura: Insights from the LATAM Hemophilia Forum 2026